SLB Quantitative Stock Analysis

Validea's guru fundamental report for Schlumberger NV (SLB), a large-cap growth stock in the Oil Well Services & Equipment sector, assigned a 66% rating based on Partha Mohanram's P/B Growth Investor model. This score, below the 80% threshold for typical investor interest, reflects the model's assessment of SLB's underlying fundamentals and valuation for sustained future growth. While SLB passed most of the model's criteria, it notably failed tests related to Return on Assets Variance, Advertising to Assets, and Capital Expenditures to Assets, indicating mixed performance against key growth indicators.

Analysis

Schlumberger NV (SLB) receives a neutral assessment from Validea's P/B Growth Investor model, scoring 66%, which is below the 80% threshold that typically indicates strategist interest. This model, based on Partha Mohanram's research, seeks low book-to-market growth stocks with fundamentals supporting sustained future growth. SLB's profile is mixed; it successfully passed criteria related to its book-to-market ratio, return on assets (ROA), cash flow from operations, sales variance, and R&D spending, suggesting underlying strengths in valuation, profitability, and innovation. However, the analysis also flags significant weaknesses. The company failed on three key tests: ROA variance, indicating inconsistent profitability over time; and both advertising-to-assets and capital-expenditures-to-assets, which, in the context of this growth model, may suggest insufficient investment in brand building and future productive capacity.

Key Decisions for Investors

• Investors should recognize that SLB does not meet the conviction threshold for a strong growth opportunity according to this specific quantitative model, as evidenced by its 66% score.
• The primary red flags to monitor are the inconsistency in Return on Assets and the relatively low levels of capital expenditure, which could temper long-term growth prospects.
• Given the mixed signals, a neutral or 'hold' stance may be warranted, while potential new investors should weigh the positive cash flow and R&D metrics against the flagged inconsistencies in profitability and reinvestment before committing capital.